Sofosbuvir
Sofosbuvir (often associated with brands like Epclusa) is a highly effective antiviral agent used to address viral load in cases of chronic liver infection. Our current catalogue features 3 formulations, including Sovaldi and Velpanat, covering the common therapeutic options required for effective management of this condition.
Key points
- Targets the NS5B polymerase enzyme that hepatitis C needs to copy its genetic material, blocking the virus from replicating.
- Used as part of combination therapy, since pairing it with other agents helps ensure the virus is fully cleared.
- Brand names for this antiviral include Sovaldi, Epclusa, Velpanat, Harvoni and Myhep, each supplied as a tablet.
What is Sofosbuvir?
Sofosbuvir is a direct-acting antiviral medication used in the clinical management of viral hepatitis. By blocking specific enzymes the virus requires to reproduce, it reduces viral activity within the host. Various brands provide consistent potency, allowing healthcare providers to tailor regimens to a patient’s specific health requirements.
What Sofosbuvir is used for
This antiviral agent is used to treat Chronic Hepatitis C. It is utilised as part of a combination therapy to ensure full viral clearance, preventing the virus from causing long-term inflammation or liver tissue damage.
How does Sofosbuvir work?
Sofosbuvir functions by targeting a specific protein, NS5B polymerase, which the hepatitis C virus uses to replicate its genetic material. When this enzyme is blocked, the virus cannot generate the copies necessary to sustain an infection. This mechanism is central to the role of Antivirals in modern medicine.
Sofosbuvir brands and forms
The market for these medications includes both original treatments and generic alternatives, such as Epclusa, Myhep, Harvoni, Sovaldi and Velpanat. These products come in forms such as Film-coated tablet and Tablet, allowing for convenient daily intake. While focusing on liver health, these treatments are sometimes relevant when managing comorbidities, including protocols related to HIV Management.
Safety overview for Sofosbuvir
What to check before using this medicine
Before commencing a course of antiviral treatment, it is necessary to assess existing liver function and evaluate current health status. Inform a healthcare provider about any other pre-existing conditions, as the status of the liver determines the suitability of specific treatment protocols.
Possible reactions and tolerability
Commonly reported observations during treatment include fatigue, headache, or mild digestive discomfort. These are generally considered part of the body’s reaction to the clearance of the virus. If symptoms persist or become concerning, clinical review is recommended.
Interactions and health factors
Sofosbuvir can interact with various other substances, particularly those affecting the liver or those used for heart conditions. Always confirm compatibility with any other medications or supplements currently in use. Product labelling and verified clinical sources remain the correct references for specific contraindications, interactions and reactions.